SynthesisESMO open2021

The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials.

A Galvano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.